Literature DB >> 24567322

DJ-1 is a copper chaperone acting on SOD1 activation.

Stefania Girotto1, Laura Cendron, Marco Bisaglia, Isabella Tessari, Stefano Mammi, Giuseppe Zanotti, Luigi Bubacco.   

Abstract

Lack of oxidative stress control is a common and often prime feature observed in many neurodegenerative diseases. Both DJ-1 and SOD1, proteins involved in familial Parkinson disease and amyotrophic lateral sclerosis, respectively, play a protective role against oxidative stress. Impaired activity and modified expression of both proteins have been observed in different neurodegenerative diseases. A potential cooperative action of DJ-1 and SOD1 in the same oxidative stress response pathway may be suggested based on a copper-mediated interaction between the two proteins reported here. To investigate the mechanisms underlying the antioxidative function of DJ-1 in relation to SOD1 activity, we investigated the ability of DJ-1 to bind copper ions. We structurally characterized a novel copper binding site involving Cys-106, and we investigated, using different techniques, the kinetics of DJ-1 binding to copper ions. The copper transfer between the two proteins was also examined using both fluorescence spectroscopy and specific biochemical assays for SOD1 activity. The structural and functional analysis of the novel DJ-1 copper binding site led us to identify a putative role for DJ-1 as a copper chaperone. Alteration of the coordination geometry of the copper ion in DJ-1 may be correlated to the physiological role of the protein, to a potential failure in metal transfer to SOD1, and to successive implications in neurodegenerative etiopathogenesis.

Entities:  

Keywords:  Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Copper; Cys-106; DJ-1; Metalloproteins; Parkinson Disease; Superoxide Dismutase (SOD)

Mesh:

Substances:

Year:  2014        PMID: 24567322      PMCID: PMC4036200          DOI: 10.1074/jbc.M113.535112

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Solution structures of the reduced and Cu(I) bound forms of the first metal binding sequence of ATP7A associated with Menkes disease.

Authors:  Tara M DeSilva; Gianluigi Veglia; Stanley J Opella
Journal:  Proteins       Date:  2005-12-01

2.  A time-resolved fluorescence study of human copper-zinc superoxide dismutase.

Authors:  N Rosato; G Mei; E Gratton; J V Bannister; W H Bannister; A Finazzi-Agrò
Journal:  Biophys Chem       Date:  1990-05       Impact factor: 2.352

3.  Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects.

Authors:  J S Lacroix; A P Ricchetti; D Morel; B Mossimann; B Waeber; E Grouzmann
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase.

Authors:  Eva Andres-Mateos; Celine Perier; Li Zhang; Beatrice Blanchard-Fillion; Todd M Greco; Bobby Thomas; Han Seok Ko; Masayuki Sasaki; Harry Ischiropoulos; Serge Przedborski; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

5.  Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme?.

Authors:  L Banci; M Benedetto; I Bertini; R Del Conte; M Piccioli; M S Viezzoli
Journal:  Biochemistry       Date:  1998-08-25       Impact factor: 3.162

6.  Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells.

Authors:  Tomoya Kinumi; Junko Kimata; Takahiro Taira; Hiroyoshi Ariga; Etsuo Niki
Journal:  Biochem Biophys Res Commun       Date:  2004-05-07       Impact factor: 3.575

7.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

8.  Oxygen and the copper chaperone CCS regulate posttranslational activation of Cu,Zn superoxide dismutase.

Authors:  Nina M Brown; Andrew S Torres; Peter E Doan; Thomas V O'Halloran
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

9.  Structure of Cu(I)-bound DJ-1 reveals a biscysteinate metal binding site at the homodimer interface: insights into mutational inactivation of DJ-1 in Parkinsonism.

Authors:  M Rhyan Puno; Nisha A Patel; Simon Geir Møller; Carol V Robinson; Peter C E Moody; Mark Odell
Journal:  J Am Chem Soc       Date:  2013-10-21       Impact factor: 15.419

10.  Conformational heterogeneity of the copper binding site in azurin. A time-resolved fluorescence study.

Authors:  A G Szabo; T M Stepanik; D M Wayner; N M Young
Journal:  Biophys J       Date:  1983-03       Impact factor: 4.033

View more
  29 in total

Review 1.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 2.  Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.

Authors:  Erin J McAllum; David I Finkelstein
Journal:  J Mol Neurosci       Date:  2016-08-08       Impact factor: 3.444

Review 3.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

4.  Imbalanced testicular metabolism induced by thyroid disorders: New evidences from quantitative proteome.

Authors:  Samantha Nascimento Gomes; Deborah Elzita do Carmo Corrêa; Isabela Medeiros de Oliveira; Paula Bargi-Souza; Monica Degraf Cavallin; Danielle Dobner Mariano; Najeh Maissar Khalil; David Livingstone Alves Figueiredo; Marco Aurelio Romano; Claudio Alvarenga de Oliveira; Renata Marino Romano
Journal:  Endocrine       Date:  2019-06-29       Impact factor: 3.633

5.  Stepwise oxidations play key roles in the structural and functional regulations of DJ-1.

Authors:  In-Kang Song; Mi-Sun Kim; James E Ferrell; Dong-Hae Shin; Kong-Joo Lee
Journal:  Biochem J       Date:  2021-10-15       Impact factor: 3.766

6.  Intracellular metal binding and redox behavior of human DJ-1.

Authors:  Letizia Barbieri; Enrico Luchinat; Lucia Banci
Journal:  J Biol Inorg Chem       Date:  2017-12-07       Impact factor: 3.358

7.  PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.

Authors:  Jeong-Yub Kim; Hee-Jin Kim; Chan-Woong Jung; Byung-Il Choi; Dae-Hee Lee; Myung-Jin Park
Journal:  Oncogene       Date:  2020-11-13       Impact factor: 9.867

8.  Production and scavenging of reactive oxygen species both affect reproductive success in male and female Drosophila melanogaster.

Authors:  Biz R Turnell; Luisa Kumpitsch; Klaus Reinhardt
Journal:  Biogerontology       Date:  2021-04-26       Impact factor: 4.277

9.  Oxidant-induced Interprotein Disulfide Formation in Cardiac Protein DJ-1 Occurs via an Interaction with Peroxiredoxin 2.

Authors:  Mariana Fernandez-Caggiano; Ewald Schröder; Hyun-Ju Cho; Joseph Burgoyne; Javier Barallobre-Barreiro; Manuel Mayr; Philip Eaton
Journal:  J Biol Chem       Date:  2016-03-04       Impact factor: 5.157

10.  Immunomodulatory role of Parkinson's disease 7 in inflammatory bowel disease.

Authors:  Rita Lippai; Apor Veres-Székely; Erna Sziksz; Yoichiro Iwakura; Domonkos Pap; Réka Rokonay; Beáta Szebeni; Gábor Lotz; Nóra J Béres; Áron Cseh; Attila J Szabó; Ádám Vannay
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.